The Modern Midlife Collective

Dr. Ade Akindipe, DNP, MBA, APRN, FNP-C and Dr. Jillian Woodruff, MD, FACOG, NCMP
  • 5.0 (4)
  • Medicine
  • Biweekly

Welcome to The Modern Midlife Collective—where midlife isn’t a crisis, it’s a rebirth. Hosted by Dr. Ade Akindipe, DNP, and Dr. Jillian Woodruff, MD, this is the podcast for women ready to unapologetically own their power, thrive through the ups and downs of hormones, weight, and self-care, and show the world that thriving at 40 and beyond isn’t just possible—it’s your birthright. Biweekly, we bring you science-backed insights on hormones, menopause, longevity, and sexual health—real tools to empower women in midlife and beyond. With a fearless blend of functional medicine, real-life wisdom, and no-nonsense empowerment, we’re here to challenge the norms, break through the barriers, and help you step into a life of vitality, confidence, and unstoppable strength. Ready to rise? Let’s do this.

  1. 2d ago

    Episode 43: Does HRT Make Your GLP-1 Work Better?

    Eating the same foods, following the same exercise routine, and doing everything that used to work, but suddenly your favorite jeans feel tighter around your waist? Or maybe you're taking a GLP-1 medication, seeing the number on the scale drop, but wondering whether you're losing fat or valuable muscle along the way. Here's something every woman in midlife deserves to understand: the number on the scale doesn't tell the whole story. In this special solo episode of The Modern Midlife Collective, Dr. Ade Akindipe explores the connection between menopause, hormone replacement therapy (HRT), GLP-1 medications, and metabolic health. Drawing on clinical experience and emerging research, Dr. Ade explains why fat distribution changes during the menopause transition, how declining estrogen can influence muscle mass and insulin sensitivity, and why visceral belly fat matters for long-term health. She also examines a question many women are asking: Does taking HRT alongside GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) lead to better weight loss results? Early observational studies suggest a possible connection, but the evidence is not yet strong enough to prove that hormone therapy directly improves GLP-1 effectiveness. ✨ This conversation will help you look beyond the scale, understand what these medications can and cannot do, and discover why protecting your muscles may be one of the most important investments you make in your health after 40. Episode Highlights Why menopause changes your body composition: What the SWAN study reveals about increased fat gain and declining lean muscle mass during the menopause transition, even when body weight barely changes.The hidden risks of visceral belly fat: Why fat stored around your internal organs is associated with insulin resistance, elevated triglycerides, fatty liver disease, and cardiovascular risk.Why the scale doesn't tell the whole story: How waist measurements, body composition scans, muscle strength, A1C, and metabolic markers provide a clearer picture of your health.HRT and weight gain: what the research actually says: Why hormone replacement therapy is not a weight loss medication and what a Cochrane review involving more than 28,000 women found about HRT and body weight.How menopause symptoms affect metabolism and daily habits: Why night sweats, poor sleep, fatigue, and increased cravings can make maintaining healthy routines more challenging.GLP-1 medications and the risk of muscle loss: How semaglutide and tirzepatide support weight and metabolic health, and why preserving lean mass matters during weight loss.Does HRT make GLP-1 medications work better? A look at three observational studies suggesting greater weight loss among some women using both therapies, and why more research is needed.Why protein and strength training matter after 40: How adequate protein intake and regular resistance exercise can help preserve muscle, support bone health, and maintain independence as you age.Medication safety and individualized treatment: Why medical supervision, reliable medication sources, monitoring, and a personalized treatment plan are essential.Three important takeaways for your next appointment: Track your body composition, understand the purpose of each medication, and protect your muscle mass for long-term health.Memorable Quotes “It's not about the size on the tag of your jeans.” – Dr. Ade “Hormone therapy is not a weight loss medication.” – Dr. Ade “It's not just how much fat on there, it's where it goes.” – Dr. Ade “They're different tools for different jobs, and sometimes a woman might need both of them.” – Dr. Ade “Protect your muscles like it's your retirement account because it kind of is.” – Dr. Ade “Your body is not broken. It is not betraying you. It is changing though.” – Dr. Ade Chapters 00:00 – Why Midlife Weight Can Shift Even When the Scale Barely Moves 03:18 – SWAN Study Findings: Fat Gain Rises as Lean Mass Declines 05:38 – Visceral Fat, Metabolic Risk, and What Body Scans Reveal 07:35 – Why Muscle Supports Metabolism and Independence 09:24 – HRT and Weight: What Randomized Evidence Does and Doesn't Show 12:08 – How Menopause Symptoms Affect Sleep, Cravings, and Activity 15:25 – How GLP-1 Medications Work and Why Muscle Loss Matters 18:14 – Medication Safety, Monitoring, and Preserving Bone and Muscle 20:09 – Protein and Strength Training as GLP-1 Essentials 21:08 – Three Studies on HRT Alongside Semaglutide and Tirzepatide 24:09 – What the Evidence Means for Deciding About HRT 25:32 – Myths, Common Questions, and Three Final Takeaways Get to know the doctors behind the insights of The Modern Midlife Collective Podcast: Dr. Aderonke "Ade" Akindipe, DNP, MBA, APRN, FNP-C A board-certified nurse practitioner and founder and medical director at Rejuvenate Health & Wellness. Dr. Ade Akindipe created The Elevated Woman Method to help women move beyond quick fixes and rediscover what it means to thrive in their bodies. With years of experience in functional medicine and lifestyle coaching, she brings a compassionate, evidence-led approach to women's health. Dr. Ade believes women aren't broken. They just need the right map back to themselves. Resources and links from Dr. Ade 🧾 Blood Sugar Balancing Blueprint: https://theelevatedwomanproject.com/episode-5-102825 💬 Book your Free 60 Metabolic Clarity Session: https://l.bttr.to/sXiAW Jillian Woodruff, MD, FACOG, NCMP Jillian Woodruff, MD, FACOG, NCMP, is a board-certified gynecologist, surgeon, and nationally certified menopause provider specializing in general and cosmetic gynecologic surgery. As Chief Medical Officer of Modern Gynecology & Skin, she specializes in hormone therapy, sexual medicine, and aesthetic treatments to help women thrive. She is the host of "Line One" on Alaska Public Media, an NPR-affiliated medical affairs radio show, and co-founder of The Women's WELL Foundation, dedicated to women's health education and access. As the co-host of The Modern Midlife Collective, she brings expertise in hormones, sexual health, aesthetics, and holistic practices, teaching women to advocate for their health and well-being in midlife with confidence. Passionate about global health, lifestyle medicine, and education, she enjoys traveling, humanitarian work, studying languages, and family life while empowering women to take charge of their health. 📩 Have a question or comment? Email us at connect@modernmidlifecollective.com—we'd love to feature your thoughts in a future episode! Follow us on Instagram for updates and behind-the-scenes content. Medical Disclaimer: This episode is for educational purposes only and does not replace personalized medical advice. Always consult your healthcare provider before starting, stopping, or changing hormone therapy or GLP-1 medications. #Menopause #Perimenopause #HormoneReplacementTherapy #HRT #GLP1 #Sem...

  2. Sep 30

    Episode 42: “Brain Fog + Hair Loss? Don’t Blame Menopause Yet: Your Iron May Not Be as ‘Normal’ as You Think”

    Brain fog? Hair shedding? Restless legs? Before you automatically blame menopause, it may be time to take another look at your iron. New 2026 guidelines are changing how iron deficiency is diagnosed, and yes, you can have iron deficiency even when you're not anemic. In Episode 42 of The Modern Midlife Collective, Dr. Jillian Woodruff and Dr. Ade Akindipe unpack the newly released American Society of Hematology guidelines on diagnosing iron deficiency. We're going beyond the symptom everyone already knows, fatigue, and talking about the signs midlife women may not associate with iron: • Brain fog and difficulty concentrating• Hair and nail changes• Restless legs• Poor exercise tolerance• Mood changes• Pica and ice chewing• Heavy menstrual bleeding during perimenopause You'll also learn why a “normal” CBC doesn't automatically rule out iron deficiency, what ferritin tells us, why laboratory reference ranges aren't always the same as clinical decision thresholds, and why finding low iron should prompt another important question: Why is the iron low in the first place? In this episode: • Iron deficiency vs. iron-deficiency anemia• The new 2026 ferritin diagnostic thresholds• Why brain fog isn't automatically menopause• The complicated connection between iron and hair loss• Heavy periods and iron depletion during perimenopause• Why postmenopausal iron-deficiency anemia needs further evaluation• Ferritin, CBC and transferrin saturation• Why you shouldn't automatically start iron supplements• Three questions to take to your next medical appointment Your three questions: What was my actual ferritin?Could I have iron deficiency even though I'm not anemic?If my iron is low, why is it low?Resources American Society of Hematology: 2026 Guidelines on Diagnosis of Iron DeficiencyCMAJ: Diagnosis and Management of Iron Deficiency in FemalesJAMA: Iron Deficiency in Adults: A ReviewAmerican Gastroenterological Association: GI Evaluation of Iron Deficiency AnemiaAmerican Academy of Sleep Medicine: Treatment of Restless Legs Syndrome Guideline The Modern Midlife CollectiveBecause thriving at 40 and beyond isn't just possible. It's your birthright.

  3. Sep 16

    Episode 41: The Estrogen Lie, Revisited

    Back in Episode 20, Dr. Jill and Dr. Ade covered the FDA's decision to walk back twenty years of black box warnings on hormone therapy. Since then, hormone therapy has become a genuine moment on social media, and not always an accurate one. In this quick-turnaround update, they separate what the newest research actually shows from what the internet is claiming, including a new Stanford study linking estrogen-only therapy to lower Alzheimer's markers, why that finding does not extend to combined therapy, and what the twenty-year-old dementia data really pins the risk on. Segment Guide Cold open: What changed since Episode 20, and why this update existsThe quick WHI recap, done right: relative risk versus absolute risk, and the age-stratified "timing hypothesis"What the FDA actually changed, and when: the November 2025 label update, and what stayed in placeWhat's actually prescribed now versus what WHI tested: bioidentical estradiol and micronized progesterone versus the oral synthetic combination used in the original trial, including how the two progestogens differ at the receptor levelThe hype swing of 2026: what hormone therapy is well-supported for, and what it is notThe new Stanford Alzheimer's study: what its three parts can and cannot tell us, and why the dementia-risk signal from 2003 traces to one specific drug, not to progesterone as a categoryWhat we'd actually tell a patient: an honest, evidence-based bottom line Key Takeaways The WHI's real numbers are absolute, not relative: about 8 additional breast cancer cases per 10,000 women per year in the combined-therapy arm, not the large-sounding relative-risk percentage that made headlines in 2002.Estrogen-alone therapy showed fewer breast cancer cases in the WHI, a reduction that reached statistical significance in longer-term follow-up along with a reduction in breast cancer mortality.Today's typical prescription, transdermal estradiol with micronized progesterone, is a different drug, different route, and different population than what the original WHI tested.A new Stanford study (Neurology, August 2026) found estrogen-only hormone therapy associated with a roughly 35 percent lower likelihood of Alzheimer's pathology markers on autopsy, plus supporting signals in dementia diagnoses and biomarkers. It is observational, not a randomized trial, and it could not address combined therapy either way due to sample size.The dementia-risk signal from the 2003 WHI Memory Study traces specifically to oral conjugated equine estrogen plus medroxyprogesterone acetate, not to progesterone or progestins as a category. Whether the micronized progesterone used today carries the same risk is a genuinely open question, not a settled no.Formulation matters. Ask your provider exactly what you are being prescribed, oral versus transdermal estrogen, and bioidentical micronized progesterone versus a synthetic progestin. Research and Sources Mentioned HHS: Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement TherapyNPR, August 7, 2026: Everyone's talking about hormone therapy for menopause. Should I be on it?STAT News, January 8, 2026: Hormone therapy for menopause is being overhyped, againStanford Medicine, August 2026: Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's riskNational Cancer Institute: Menopausal Estrogen Therapy Benefits and Risks Vary by Age (WHI analysis)International Menopause Society: Lessons from KEEPS, the Kronos Early Estrogen Prevention StudyShumaker et al., JAMA, 2003: Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment (WHI Memory Study)Barth et al., Lancet Diabetes & Endocrinology, 2023: Sex Steroids and the Female Brain Across the LifespanVinogradova et al., BMJ, 2021: Use of menopausal hormone therapy and risk of dementia (UK QResearch/CPRD cohort)Savolainen-Peltonen et al., BMJ, 2019: Use of Postmenopausal Hormone Therapy and Risk of Alzheimer's Disease in FinlandGleason et al., PLOS Medicine, 2015: Effects of Hormone Therapy on Cognition and Mood (KEEPS-Cognitive and Affective Study) A Note on This Episode This episode is for educational purposes and reflects Dr. Jill and Dr. Ade's read of the current evidence. It is not personalized medical advice. Hormone therapy decisions depend on individual history, and listeners should talk with their own healthcare provider before starting, stopping, or changing any hormone therapy. Connect With Us Have a question about your own hormone therapy, or a topic you want us to cover? Email connect@modernmidlifecollective.com or visit www.modernmidlifecollective.com for links to everything mentioned in this episode. If this episode was useful, follow or subscribe wherever you listen, and consider leaving a rating and review. It genuinely helps other midlife women find the show.

  4. Sep 2

    Episode 40: “Why Can't I Drink Like I Used To? The Truth About Alcohol in Perimenopause”

    One completely ordinary glass of wine. Then suddenly you’re awake at 3 a.m., your heart is racing, you’re hot, your sleep is wrecked, your stomach feels off—and the next morning feels suspiciously like a hangover that should have required a much bigger night out. Sound familiar? In this episode of The Modern Midlife Collective, Dr. Jillian and Dr. Ade explore why many women notice that alcohol affects them differently during perimenopause and menopause. And while hormones are part of the conversation, the answer is much more nuanced than “your estrogen dropped.” Alcohol is landing in a body that may now have different body composition, total body water, sleep architecture, medications, metabolic demands and nervous-system vulnerability—all while estrogen is becoming increasingly unpredictable during the menopause transition. This episode is about recalibration, not perfection. No shame. No judgment. No gold stars for abstinence. Just better information. IN THIS EPISODE Dr. Jillian and Dr. Ade discuss: Why alcohol may suddenly feel stronger in midlifeWhy perimenopause is better described as hormonal turbulence than a simple estrogen declineHow alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH2) metabolize alcoholWhy genetic differences can dramatically affect alcohol toleranceHow lower total body water can contribute to higher blood-alcohol concentrationsAge-related changes that may affect the “bounce-back”Why alcohol may make you sleepy while still disrupting restorative sleepREM sleep and those notorious 3 a.m. awakenings“Hangxiety” and the nervous-system rebound after alcoholAlcohol as a potential hot-flash or night-sweat triggerWhy different drinks may feel different—even though ethanol is still ethanolHistamine, sulfites and why red wine may suddenly make some women miserableWhy “red wine is good for your heart” deserves more nuanceAlcohol and breast-cancer riskAlcohol’s effects on appetite, weight-management goals and training recoveryWhat to consider if you are taking a GLP-1 medicationBladder urgency, frequency and menopause-related genitourinary symptomsWhy new medications may change your alcohol toleranceWhat we know—and still don’t know—about alcohol and the gut microbiomeHormonal and evidence-based nonhormonal options for bothersome hot flashes and night sweatsThe Two-Week “Does Alcohol Actually Like Me?” ExperimentKEY TAKEAWAYS 1. It probably isn’t just one hormone. Estrogen and alcohol do interact, and research has found associations between alcohol exposure and estradiol levels. But current evidence does not support reducing midlife alcohol intolerance to a simple story in which fluctuating estrogen directly “switches off” ADH or ALDH2. Aging, genetics, body composition, sleep, medications, liver physiology and the menopause transition can all overlap. 2. The same drink may be landing in a different body.Alcohol distributes through body water. Changes in body composition with aging—including loss of lean tissue when muscle is not actively preserved—can change the physiologic context in which alcohol is consumed. That is one more reason strength training, protein intake and maintenance of lean mass matter in midlife. 3. Being able to “hold your liquor” doesn’t make alcohol harmless.Tolerance describes how intoxicated you feel. It does not mean other physiologic effects disappear. 4. Alcohol may help you fall asleep—but that doesn’t make it a sleep treatment.A 2025 systematic review and meta-analysis of 27 studies found that alcohol altered sleep architecture, including delayed REM onset and reduced REM sleep. REM disruption was seen even at relatively low doses and worsened as alcohol intake increased. (PubMed⁠) 5. Red wine is not cardiovascular medicine.Some observational studies historically suggested cardiovascular benefits from light-to-moderate alcohol use, but newer analyses have challenged a clear protective effect. The American Heart Association advises people who do not currently drink not to start drinking for health benefits. (professional.heart.org⁠) 6. Alcohol and breast-cancer risk deserve an honest conversation.Alcohol is a known human carcinogen. NIAAA currently notes that even approximately one drink per day is associated with a 5% to 15% higher breast-cancer risk compared with women who do not drink. That statistic describes population-level risk. It does not mean one glass of wine “causes” breast cancer in an individual woman. It is information women deserve when deciding what level of alcohol exposure feels acceptable to them. (NIAAA⁠) 7. Know what “one drink” actually means.In the United States, one standard drink contains approximately 14 grams of pure alcohol: 12 oz regular beer at about 5% ABV5 oz wine at about 12% ABV1.5 oz distilled spirits at about 40% ABV A cocktail, restaurant pour or large home wine glass may contain more than one standard drink. (NIAAA⁠) 8. You do not have to simply tolerate disruptive hot flashes.Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms for appropriate candidates. Women who do not want—or are not candidates for—hormone therapy also have evidence-based nonhormonal choices. (The Menopause Society⁠) Newer nonhormonal options include neurokinin-targeting therapies. Fezolinetant is FDA approved for moderate-to-severe menopausal hot flashes and carries a boxed warning regarding rare serious liver injury. Elinzanetant received FDA approval on October 24, 2025, for moderate-to-severe vasomotor symptoms due to menopause. (U.S. Food and Drug Administration⁠) THE TWO-WEEK “DOES ALCOHOL ACTUALLY LIKE ME?” EXPERIMENT For 14 days, eliminate alcohol—or reduce it enough to create a meaningful comparison. Track: 1. Sleep quality How quickly did you fall asleep? Did you stay asleep? How rested were you the next morning? 2. Hot flashes/night sweats Frequency, intensity and nighttime awakenings. 3. Morning energy Clearheaded? Sluggish? Headache? Puffy?

  5. Aug 12

    Episode 39: “The Pellet Factory Problem: Why One-Size-Fits-All Hormone Therapy Should Worry You”

    Hormone pellets are everywhere—from social media ads to hormone clinics promising more energy, better libido, improved strength, and an easier way to manage menopause symptoms. But are hormone pellets actually right for you? In this episode of The Modern Midlife Collective, Dr. Jillian Woodruff and Dr. Ade Akindipe take an evidence-based look at bioidentical hormone pellets—what they are, how they work, where they may be helpful, and the important trade-offs you should understand before having one inserted. They also tackle one of the biggest misconceptions in hormone therapy: the word “bioidentical.” Bioidentical doesn't automatically mean safer, more natural, or customized. It describes the molecular structure of the hormone—and many FDA-approved hormone therapy options are bioidentical too. And there’s another important consideration with pellets: once a pellet is inserted, the dose cannot simply be turned down or adjusted the way it can with a patch, gel, or pill. You're committing to that delivery method for the life of the pellet. That doesn't mean pellets are inherently bad. For the right patient, with thoughtful dosing and appropriate monitoring, they may be a useful option. The key word is individualized. ✨ Hormone therapy should fit the patient—not the clinic's business model.✨ “Bioidentical” doesn't automatically mean “safer.”✨ And no single hormone delivery method is right for every woman. In this episode, we discuss: What bioidentical hormone pellets actually are and how they workWhat “bioidentical” really means—and what it doesn'tThe difference between compounded pellets and FDA-approved hormone therapyWhy pellets can sometimes produce supraphysiologic, or above-normal, hormone levelsThe biggest limitation of pellets: why dosing can't easily be adjusted once they're insertedWhy appropriate monitoring matters throughout hormone therapyThe importance of progesterone when estrogen is used in women with a uterusThe potential role of testosterone in libido, energy, and muscle strengthWhy the goal of testosterone therapy should be symptom improvement—not chasing the highest hormone levelWho may be a good candidate for hormone pelletsQuestions to ask before choosing a hormone delivery methodWhy a clinic that offers the exact same treatment to every patient should make you ask more questionsThe truth about hormone pellets Hormone pellets aren't automatically “good” or “bad.” They're one delivery method among several. The right hormone therapy depends on your symptoms, medical history, individual risk factors, treatment goals, response to therapy, and appropriate clinical monitoring. Pellets also come with a unique trade-off: unlike some other hormone delivery methods, the dose cannot be easily changed after insertion. That's why an informed conversation before treatment matters. If every patient who walks through a clinic's door is offered the same hormone treatment—regardless of her history, symptoms, or individual needs—that isn't truly personalized hormone care. You deserve to understand your options, the benefits, the limitations, and the risks before making your decision. Key Takeaway There is no one-size-fits-all approach to hormone therapy. Pellets may be appropriate for some women, while patches, gels, creams, oral medications, or other approaches may make more sense for others. The goal isn't to choose the trendiest delivery method. It's to choose the right treatment, at the right dose, for the right patient—with appropriate follow-up and monitoring. 🎧 Considering hormone pellets—or already using them? Listen before your next appointment and bring your questions with you. If this episode helped clarify your options, share it with another woman navigating hormone therapy in midlife. Download Your Free Hormone Therapy Methods Guide 📩 Have a question or topic you'd like us to discuss? Visit modernmidlifecollective.com or email us at connect@modernmidlifecollective.com. Resources Mentioned The Menopause Society — Hormone therapy information and clinical guidanceAmerican College of Obstetricians and Gynecologists (ACOG) — Guidance on compounded bioidentical menopausal hormone therapyWomen's Health Initiative — Research and long-term follow-up on menopausal hormone therapyReviews published in American Journal of Obstetrics & Gynecology and Obstetrics & Gynecology addressing compounded hormone therapy and endometrial safety#HormonePellets#BioidenticalHormones#HormoneTherapy#HRT#Perimenopause#MenopauseSupport#HormoneHealth#WomenOver40#MidlifeWellness#ModernMidlifeCollective

  6. Jul 29

    Episode 38: Brain Fog, ADHD, or Both? How Perimenopause Changes Your Brain

    Is that brain fog… or something more? Dr. Jillian and Dr. Ade break down how to actually tell the difference between perimenopausal brain fog, adult ADHD, and the surprisingly common overlap between the two — plus why so many women are only being diagnosed with ADHD for the first time in their 40s and 50s. They walk through the clues that separate the two, the estrogen-dopamine connection driving it all, how it shows up in relationships and parenting, and exactly what to say at your next appointment. SHOW NOTES If the brain you’ve relied on for decades suddenly feels unreliable, you’re not lazy, careless, or incapable — and you may be one of three things: experiencing genuine perimenopausal brain fog, uncovering ADHD that’s been masked for decades, or dealing with both at once. In this episode, Dr. Jillian and Dr. Ade walk through the exact framework they use in clinic to help you tell the difference. In this episode: What ADHD actually is: current presentations (predominantly inattentive, predominantly hyperactive-impulsive, combined), and why “ADD” is now called ADHD, predominantly inattentive presentationThe three-bucket framework: perimenopausal cognitive change, undiagnosed ADHD surfacing, or both togetherFour clues that help separate them — timing and history, how broad the symptoms are, where they show up, and how much effort it’s taken to compensateThe estrogen-dopamine connection: why hormonal transition changes the environment attention and executive function operate inWhy so many women are only recognizing ADHD in midlife, and the historical gap in how girls were diagnosedHow this shows up at the kitchen table — in marriages, parenting, and intimacyWhat actually helps, and exactly what to say at your next appointmentBy the numbers: Nearly 60% of perimenopausal women report real memory complaints, per the Study of Women’s Health Across the Nation (SWAN)A 2025 population-based study of over 5,300 women (the Icelandic SAGA cohort) found 54.2% of women with a self-reported ADHD diagnosis experienced debilitating perimenopausal symptoms, compared to about a third of women without ADHDResources & sources referenced: Study of Women’s Health Across the Nation (SWAN) — longitudinal research on cognition and symptoms across the menopause transitionWeber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology.Jakobsdóttir Smári, U., et al. (2025). Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. European Psychiatry.Kooij, J. J. S., et al. (2025). Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Frontiers in Global Women’s Health.Osianlis, E., et al. (2025). ADHD and sex hormones in females: A systematic review. Journal of Attention Disorders.DSM-5-TR. American Psychiatric Association. (2022). ADHD diagnostic criteria and presentation terminology.Have a question or want to learn more? Reach out at connect@modernmidlifecollective.com. DR. JILLIAN “If the brain you have relied on for forty years suddenly feels unreliable, you are not becoming lazy, careless, or incapable.” “The coping did not fail. The floor moved. Now the support system has to move with it.” DR. ADE “Success does not rule out ADHD. The more useful question is: what did that success cost?” “You do not need to be falling apart dramatically before asking for help. Quietly working twice as hard to maintain the same life is enough.”

  7. Jul 15

    Episode 37: "I Think I'm in Perimenopause — When Do I Start Progesterone?"

    If you're in your late 30s or 40s, waking up at 3 a.m., and wondering why your anxiety is through the roof and your cycles are changing — this episode is for you. Dr. Jill and Dr. Ade break down everything you need to know about perimenopause and progesterone: what progesterone actually does (hint: it's way more than a "pregnancy hormone"), why bioidentical progesterone is different from synthetic progestins, and the clinical decision framework for when to start. Real science. No fear. Just answers. In Episode 37, Dr. Jill Woodruff (gynecologist and certified menopause practitioner) and Dr. Ade Akindipe (DNP, functional medicine specialist) tackle the most common question they hear from women in their 40s: "I think I'm in perimenopause — when do I start progesterone?" This episode covers: What perimenopause actually is and when it starts (hint: much earlier than you think) Why progesterone is often the first hormone to decline — and what that means for your sleep, mood, and cycles The critical difference between bioidentical progesterone and synthetic progestins Why the Women's Health Initiative doesn't apply to modern bioidentical hormone therapy Three clinical scenarios where progesterone is indicated in perimenopause How to talk to your provider and advocate for the care you deserve GUEST DETAILS: This is a co-host episode featuring Dr. Jillian Woodruff, MD, FACOG, NCMP (CMO, Modern Gynecology & Skin) and Dr. Ade Akindipe, DNP, MBA, APRN, FNP-C (Founder, Rejuvenate Health and Wellness).

  8. Jul 1

    Episode 36: The Menopause Toolkit Every Woman Needs Before Her Next Doctor's Visit

    What happens when a patient decides she deserves better? After experiencing years of frustrating symptoms and feeling dismissed by the healthcare system, Angela Jackson, LMSW, turned her own journey into a mission to help other women.  In this episode, Angela shares the story behind her graduate capstone project—a comprehensive Perimenopause & Menopause Toolkit designed to educate women, improve communication with healthcare providers, and empower patients to become active participants in their own care. The toolkit is available as a free download in the resources below. Together, Dr. Jillian Woodruff and Dr. Ade Akindipe explore why so many women remain undiagnosed during perimenopause, the importance of recognizing early symptoms, racial disparities in menopause care, and how patients and providers can work together to create better outcomes. This conversation is a reminder that menopause isn't simply something to survive—it's a life transition women can navigate with knowledge, partnership, and confidence. What You'll Learn Why women are frequently dismissed during perimenopauseThe hidden symptoms many women overlookHow to prepare for your next healthcare appointmentWhy patient self-advocacy changes healthcare outcomesThe importance of provider-patient collaborationWhat health equity means in menopause careWhy thriving—not suffering—should be the goal Featured Guest Angela Jackson, LMSW Angela Jackson recently earned her Master of Social Work and developed a Perimenopause & Menopause Toolkit as her graduate capstone project. Grounded in trauma-informed care, patient empowerment, and health equity, the toolkit helps women understand symptoms, prepare for medical appointments, and confidently advocate for their healthcare needs. Key Takeaways You know your body better than anyone else.Your symptoms deserve to be taken seriously.Perimenopause often begins years before menopause.Being informed allows you to become an active participant in your healthcare.The best healthcare happens through partnership—not one-sided conversations.Every woman deserves to thrive during midlife. Suggested Chapter Markers 00:00 – Why women often feel dismissed 02:45 – Meet Angela Jackson 06:00 – The inspiration behind the Menopause Toolkit 12:00 – Learning to advocate for yourself 16:30 – Building a toolkit for patients and providers 20:00 – Racial disparities in menopause care 24:00 – Why earlier conversations matter 30:00 – Practical advice for your next doctor's appointment 35:00 – Final reflections Resources Mentioned Perimenopause symptom awarenessPatient self-advocacyShared decision-making between patients and providersTrauma-informed healthcareSWAN (Study of Women's Health Across the Nation)Free Download 📥 Download Angela Jackson's Perimenopause & Menopause Toolkit Angela created this comprehensive educational toolkit to help women better understand perimenopause and menopause, recognize common symptoms, prepare for healthcare appointments, and confidently advocate for their care. Whether you're just beginning to notice changes or you're already navigating menopause, this free resource is designed to help you feel informed, empowered, and prepared. 👉 Download the toolkit here

See All (43)

5
out of 5
4 Ratings

About

Welcome to The Modern Midlife Collective—where midlife isn’t a crisis, it’s a rebirth. Hosted by Dr. Ade Akindipe, DNP, and Dr. Jillian Woodruff, MD, this is the podcast for women ready to unapologetically own their power, thrive through the ups and downs of hormones, weight, and self-care, and show the world that thriving at 40 and beyond isn’t just possible—it’s your birthright. Biweekly, we bring you science-backed insights on hormones, menopause, longevity, and sexual health—real tools to empower women in midlife and beyond. With a fearless blend of functional medicine, real-life wisdom, and no-nonsense empowerment, we’re here to challenge the norms, break through the barriers, and help you step into a life of vitality, confidence, and unstoppable strength. Ready to rise? Let’s do this.

Information

  • Creator
    Dr. Ade Akindipe, DNP, MBA, APRN, FNP-C and Dr. Jillian Woodruff, MD, FACOG, NCMP
  • Years Active
    2025 - 2026
  • Episodes
    43
  • Rating
    Clean
  • Copyright
    © 2026 Dr. Ade Akindipe, DNP, MBA, APRN, FNP-C and Dr. Jillian Woodruff, MD, FACOG, NCMP

You Might Also Like